Krakow, Poland · Founded 2017 · Privately Held (backing)
Operator of a medical technology intended to treat several autoimmune diseases. Ongeno is based in Krakow, Poland and was founded in 2017. Its last reported valuation was $72.6 million in Jan 2025. It has raised $3.6 million.
Last reported valuation
$72.6M
Oct 2026
Priced at
—
Total raised
$3.6M
Last round
—
Team — not yet on record
No current team members for Ongeno are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ongeno with a free account
·Watch Ongeno: the Monday email on marks, rounds and moves
